Laing C M, Unwin R J
Centre for Nephrology and Department of Physiology, Royal Free and University College Medical School, Royal Free, London, UK.
J Nephrol. 2006 Mar-Apr;19 Suppl 9:S46-52.
Renal tubular acidosis (RTA) is a form of metabolic acidosis due to abnormal alkali (bicarbonate) loss by the kidneys or their failure to excrete net acid. While the latter does occur in chronic renal failure, the term RTA is usually applied only when the glomerular filtration rate is normal or near normal. As well as a cause of metabolic acidosis, RTA often presents as renal stone disease with nephrocalcinosis, rickets/osteomalacia, and growth retardation in children. In this brief review, we have summarized the classification, clinical features and the underlying cell and molecular pathophysiology of RTA. However, despite significant advances in our understanding of the mechanisms of RTA, its treatment is still empirical and based largely on alkali replacement therapy; but its wider significance in renal stone and bone disease is becoming increasingly recognized.
肾小管酸中毒(RTA)是一种代谢性酸中毒,其原因是肾脏碱(碳酸氢盐)异常丢失或肾脏无法排泄净酸。虽然后者确实发生在慢性肾衰竭中,但术语RTA通常仅在肾小球滤过率正常或接近正常时使用。作为代谢性酸中毒的一个原因,RTA常表现为伴有肾钙质沉着症的肾结石病、佝偻病/骨软化症以及儿童生长发育迟缓。在这篇简短的综述中,我们总结了RTA的分类、临床特征以及潜在的细胞和分子病理生理学。然而,尽管我们对RTA机制的理解取得了重大进展,其治疗仍然是经验性的,主要基于碱替代疗法;但其在肾结石和骨病方面更广泛的意义正日益得到认可。